Letter to the Editor From Min Gong et al: "Risk for Infections During Treatment With Denosumab for Osteoporosis: A Systematic Review and Meta-analysis"
J Clin Endocrinol Metab
.
2020 Sep 1;105(9):dgaa445.
doi: 10.1210/clinem/dgaa445.
Authors
Min Gong
1
,
Guangping Huang
2
,
Chang Xu
3
4
Affiliations
1
Department of Orthopaedic Surgery, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
2
Department of Orthopaedic Surgery, The People's Hospital of Jianyang City, Chengdu, Sichuan, China.
3
Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, China.
4
Department of Population Medicine, College of Medicine, Qatar University, Doha, Qatar.
PMID:
32678872
DOI:
10.1210/clinem/dgaa445
No abstract available
Publication types
Letter
Comment
MeSH terms
Bone Density Conservation Agents* / adverse effects
Denosumab / adverse effects
Humans
Osteoporosis* / drug therapy
Substances
Bone Density Conservation Agents
Denosumab